SQY Therapeutics
PrivateLast Round
Grant
Nov 27, 2025
Total Funding Raised
$348,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
SQY Therapeutics operates in Healthcare & Life Sciences and is based in Guyancourt. Its latest recorded funding round was a Grant round in November 2025.
SQY Therapeutics is a biotechnology company that develops antisense oligonucleotide therapies for the treatment of genetic diseases, particularly Duchenne muscular dystrophy.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SQY Therapeutics Comparables
Compare SQY Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shift Pharmaceuticals | 81% | |
| Dyne Therapeutics | 78% | |
| Entrada Therapeutics | 76% |
For institutional investors. Book with your work email.
SQY Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
SQY Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Région Île-de-France | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 15, 2026
Grew 24% QoQ, from 21 to 26 employees.
- May 12, 2026
Monthly visitors increased 77% MoM.
For institutional investors. Book with your work email.
SQY Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SQY Therapeutics's valuation, stock price, and market status.
Is SQY Therapeutics a public or private company?
SQY Therapeutics is a private company.
What is the current stock price of SQY Therapeutics?
SQY Therapeutics is a private company, so its shares have no public market price. Caplight tracks SQY Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SQY Therapeutics worth (valuation)?
Valuation information for SQY Therapeutics is not publicly available.
Can I buy SQY Therapeutics stock?
SQY Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SQY Therapeutics's last funding round?
SQY Therapeutics's most recent funding round was Grant on November 27, 2025.
Who are the main investors in SQY Therapeutics?
Key investors in SQY Therapeutics include Région Île-de-France.
Will SQY Therapeutics IPO soon?
No public IPO plans have been announced for SQY Therapeutics.
How can I track SQY Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in SQY Therapeutics's shares on secondary markets.